MUNA JABBOUR: Open Payments
NPI 1679535751 · NEW STANTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,052 in 67 payments from 17 companies in 2025. Trend: 2023 $2,167 · 2024 $1,839 · 2025 $2,052
Food & beverage: $2,052
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $880 |
| ABBVIE INC. | 13 | $324 |
| Novo Nordisk Inc | 7 | $229 |
| Lilly USA, LLC | 4 | $97 |
| PFIZER INC. | 4 | $84 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| Aimmune Therapeutics, Inc. | 3 | $65 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Exact Sciences Corporation | 3 | $52 |
| Merck Sharp & Dohme LLC | 2 | $34 |
Products named: BREZTRI, AIRSUPRA, QULIPTA, EMBLAVEO, MOUNJARO, REXULTI, ZENPEP, FARXIGA.
Industry payments across PA — which companies pay providers there.
